Editorial: Disease-modifying antirheumatic drugs: Approaches and lessons learned from traditional medicine

被引：3
作者：
Mei, Liyan [1 ]
Gao, Kaixin [1 ]
He, Xiaojuan [2 ]
Jakobsson, Per-Johan [3 ]
Huang, Runyue [1 ,4 ,5 ,6 ]
机构：
[1] Guangzhou Univ Chinese Med, Affiliated Hosp 2, Guangdong Prov Hosp Chinese Med, Guangzhou, Peoples R China
[2] China Acad Chinese Med Sci, Beijing, Peoples R China
[3] Karolinska Inst KI, Solna, Sweden
[4] Guangzhou Univ Chinese Med, Guangdong Hong Kong Macau Joint Lab Chinese Med &, Hong Kong, Guangdong, Peoples R China
[5] Guangzhou Univ Chinese Med, State Key Lab Dampness Syndrome Chinese Med, Affiliated Hosp 2, Guangzhou, Peoples R China
[6] Guangdong Prov Key Lab Clin Res Tradit Chinese Med, Guangzhou, Peoples R China
来源：
FRONTIERS IN PHARMACOLOGY | 2023年 / 14卷
关键词：
disease-modifying antirheumatic drugs (DMARDs); traditional Chinese medicine (TCM); DMARDs-like effects; rheumatic diseases; new strategies; RHEUMATOID-ARTHRITIS; SAFETY;
D O I：
10.3389/fphar.2023.1135803
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页数：3
相关论文
共 50 条
[41]   Time to initiation of biologic disease-modifying antirheumatic drugs in the French cohort ESPOIR [J].
Kedra, Joanna ;
Granger, Benjamin ;
Emilie, Stephanie ;
Gaujoux-Viala, Cecile ;
Rat, Anne-Christine ;
Combe, Bernard ;
Fautrel, Bruno .
JOINT BONE SPINE, 2021, 88 (01)
[42]   Treatment adherence to disease-modifying antirheumatic drugs in Chinese patients with rheumatoid arthritis [J].
Xia, Yunfei ;
Yin, Rulan ;
Fu, Ting ;
Zhang, Lijuan ;
Zhang, Qiuxiang ;
Guo, Genkai ;
Li, Liren ;
Gu, Zhifeng .
PATIENT PREFERENCE AND ADHERENCE, 2016, 10 :735-742
[43]   >Efficacy of disease-modifying antirheumatic drugs in the treatment of granulomatous mastitis: a systematic review [J].
Parperis, Konstantinos ;
Costi, Egli ;
Philippou, Sofia ;
Hadi, Mohanad ;
Derk, Chris T. .
RHEUMATOLOGY INTERNATIONAL, 2024, 44 (11) :2371-2379
[44]   High Degree of Nonadherence to Disease-modifying Antirheumatic Drugs in Patients with Rheumatoid Arthritis [J].
Rauscher, Veronika ;
Englbrecht, Matthias ;
van der Heijde, Desiree ;
Schett, Georg ;
Hueber, Axel J. .
JOURNAL OF RHEUMATOLOGY, 2015, 42 (03) :386-390
[45]   Corneal melt in rheumatic disorders - Effect of disease-modifying antirheumatic drugs on morbidity [J].
Saripalli, L ;
Harrington, TM ;
Notz, RG ;
Torretti, D .
JCR-JOURNAL OF CLINICAL RHEUMATOLOGY, 2005, 11 (03) :134-139
[46]   Disease-modifying antirheumatic drugs improve cardiovascular autonomic neuropathy in psoriatic arthritis [J].
Syngle, Ashit ;
Verma, Inderjeet ;
Krishan, Pawan ;
Syngle, Vijaita .
THERAPEUTIC ADVANCES IN MUSCULOSKELETAL DISEASE, 2016, 8 (02) :42-48
[47]   New proven disease-modifying antirheumatic substances [J].
Schattenkirchner, M .
ZEITSCHRIFT FUR RHEUMATOLOGIE, 2001, 60 (06) :473-476
[48]   IGURATIMOD: A NEW DISEASE-MODIFYING ANTIRHEUMATIC DRUG [J].
Mucke, H. A. M. .
DRUGS OF TODAY, 2012, 48 (09) :577-586
[49]   Personalized medicine in the choice of conventional immunosuppressants and disease modifying antirheumatic drugs [J].
Fiehn, C. ;
Keysser, G. ;
Lorenz, H. -M. .
ZEITSCHRIFT FUR RHEUMATOLOGIE, 2013, 72 (01) :27-+
[50]   The Biological Disease-Modifying Antirheumatic Drugs and the Risk of Cardiovascular Events: A Systematic Review and Meta-Analysis [J].
Hu, Suiyuan ;
Lin, Chu ;
Cai, Xiaoling ;
Zhu, Xingyun ;
Lv, Fang ;
Nie, Lin ;
Ji, Linong .
MEDIATORS OF INFLAMMATION, 2021, 2021
12345